RESUMEN
Diminazene aceturate (DA) and imidocarb dipropionate are commonly used in livestock as antipiroplasm agents. However, toxic side effects are common in animals treated with these two drugs. Therefore, evaluations of novel therapeutic agents with high efficacy against piroplasm parasites and low toxicity to host animals are of paramount importance. In this study, the 400 compounds in the Pathogen Box provided by the Medicines for Malaria Venture foundation were screened against Babesia bovis, Babesia bigemina, Babesia caballi, and Theileria equi. A fluorescence-based method using SYBR Green 1 stain was used for initial in vitro screening and determination of the half maximal inhibitory concentration (IC50). The initial in vitro screening performed using a 1⯵M concentration as baseline revealed nine effective compounds against four tested parasites. Two "hit" compounds, namely MMV021057 and MMV675968, that showed IC50â¯<â¯0.3⯵M and a selectivity index (SI)> 100 were selected. The IC50s of MMV021057 and MMV675968 against B. bovis, B. bigemina, T. equi and B. caballi were 23, 39, 229, and 146â¯nM, and 2.9, 3, 25.7, and 2.9â¯nM, respectively. In addition, a combination of MMV021057 and DA showed additive or synergistic effects against four tested parasites, while combinations of MMV021057 with MMV675968 and of MMV675968 with DA showed antagonistic effects. In mice, treated with 50â¯mg/kg MMV021057 and 25â¯mg/kg MMV675968 inhibited the growth of Babesia microti by 54 and 64%, respectively, as compared to the untreated group on day 8. Interestingly, a combination treatment with 6.25â¯mg/kg DA and 25â¯mg/kg MMV021057 inhibited B. microti by 91.6%, which was a stronger inhibition than that by single treatments with 50â¯mg/kg MMV021057 and 25â¯mg/kg DA, which showed 54 and 83% inhibition, respectively. Our findings indicated that MMV021057, MMV675968, and the combination treatment with MMV021057 and DA are prospects for further development of antipiroplasm drugs.
Asunto(s)
Antipruriginosos/administración & dosificación , Babesia/efectos de los fármacos , Babesiosis/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Eritrocitos/parasitología , Theileria/efectos de los fármacos , Theileriosis/tratamiento farmacológico , Animales , Babesia/fisiología , Babesiosis/sangre , Babesiosis/parasitología , Bovinos , Sinergismo Farmacológico , Quimioterapia Combinada , Femenino , Humanos , Concentración 50 Inhibidora , Masculino , Ratones , Ratones Endogámicos BALB C , Theileria/fisiología , Theileriosis/sangre , Theileriosis/parasitologíaRESUMEN
In this study an increased SUSPPUP ratio and fractional excretion of potassium in dogs infected with Babesia canis suggested mineralocorticoid excess in canine babesiosis. A significant increase in strong monovalent electrolyte fractional excretions in azotaemic dogs infected with B. canis probably resulted from acute tubular necrosis.
Asunto(s)
Babesiosis/veterinaria , Enfermedades de los Perros/metabolismo , Fósforo/sangre , Fósforo/orina , Sodio/sangre , Sodio/orina , Animales , Babesiosis/sangre , Babesiosis/orina , Enfermedades de los Perros/sangre , Enfermedades de los Perros/orina , Perros , Electrólitos/sangre , Electrólitos/orina , Equilibrio HidroelectrolíticoRESUMEN
(-)-Epigallocatechin-3-gallate (EGCG) is the major tea catechin and accounts for 50-80% of the total catechin in green tea. (-)-Epigallocatechin-3-gallate has antioxidant, anti-inflammatory, anti-microbial, anti-cancer, and anti-trypanocidal activities. This report describes the inhibitory effect of (-)-Epigallocatechin-3-gallate on the in vitro growth of bovine Babesia parasites and the in vivo growth of the mouse-adapted rodent babesia B. microti. The in vitro growth of the Babesia species was significantly (P<0.05) inhibited in the presence of micromolar concentrations of EGCG (IC50 values=18 and 25 microM for B. bovis, and B. bigemina, respectively). The parasites showed no re-growth at 25 microM for B. bovis and B. bigemina in the subsequent viability test. The drug significantly (P<0.05) inhibited the growth of B. microti at doses of 5 and 10 mg/kg body weight, and the parasites completely cleared on day 14 and 16 post-inoculation in the 5 and 10 mg/kg treated groups, respectively. These findings highlight the potentiality of (-)-Epigallocatechin-3-gallate as a chemotherapeutic drug for the treatment of babesiosis.
Asunto(s)
Babesia/efectos de los fármacos , Camellia sinensis/química , Catequina/análogos & derivados , Animales , Babesia/crecimiento & desarrollo , Babesiosis/sangre , Babesiosis/parasitología , Catequina/farmacología , Eritrocitos/parasitología , Femenino , Concentración 50 Inhibidora , Ratones , Ratones Endogámicos BALB C , Parasitemia/sangre , Parasitemia/tratamiento farmacológicoRESUMEN
This study investigated the practicality and potential of the gerbil, Meriones unguiculatus, as a source of live Babesia divergens vaccine and also as a model for the use of the vaccine in cattle. A series of experiments with gerbils concerning vaccine infectivity, immunogenicity and safety were carried out. It was concluded that the use of RPMI medium/40% foetal calf serum as a diluent improved vaccine infectivity, but that the parasitaemia of the blood obtained from donor gerbils had little or no effect. The immunostimulants levamisole and killed Corynebacterium parvum improved vaccine immunogenicity and it was also shown that the subcutaneous route of infection resulted in the greatest host response. Control of vaccine virulence with drugs was only possible when drugs with prophylactic properties, such as imidocarb and long-acting oxytetracycline, were used. More studies are required on all these topics, particularly with regard to their applicability to cattle, and also concerning the possible attenuation of the parasite by manipulation in the gerbil host.
Asunto(s)
Babesiosis/prevención & control , Enfermedades de los Bovinos/prevención & control , Modelos Animales de Enfermedad , Gerbillinae , Vacunación/veterinaria , Adyuvantes Inmunológicos , Animales , Babesia/inmunología , Babesiosis/sangre , Bovinos , Enfermedades de los Bovinos/sangre , Diminazeno/análogos & derivados , Diminazeno/farmacología , Femenino , Imidocarbo/farmacología , Levamisol/inmunología , Masculino , Oxitetraciclina/farmacología , Propionibacterium acnes/inmunología , Vacunas Antiprotozoos , Esplenectomía/veterinaria , Virulencia/efectos de los fármacosAsunto(s)
Babesiosis/tratamiento farmacológico , Eritrocitos/parasitología , Mitomicinas/uso terapéutico , Animales , Babesiosis/sangre , Babesiosis/parasitología , Evaluación Preclínica de Medicamentos , Eritrocitos/efectos de los fármacos , Femenino , Técnicas In Vitro , Ratones , Ratones Endogámicos , Mitomicina , Reticulocitos/efectos de los fármacos , Reticulocitos/parasitología , Factores de TiempoRESUMEN
Investigations were carried out on the serum enzymes, total proteins and some electrolites (potassium and sodium) in eight spleenectomized sheep experimentally infected with Babesia organisms. It was found that babesiasis in sheep was accompanied by a considerable rise in the activity of GOT and GPT (from 80JU up to 260IU and from 4 IU up to 19 IU). The amount of inorganic phosphorus dropped, and that of potassium sodium and alkaline phosphatase showed no changes. It is believed that the changes in the activity of GOT, GPT and inorganic phosphorus depend on the gravity and the duration of the disease and can be used as a criterion in determining the pathologic process.